Patents by Inventor Michael D. Finch

Michael D. Finch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220267367
    Abstract: Methods of preventing or retarding or reversing or abolishing the onset of Parkinson's and other neurodegenerative diseases are discussed.
    Type: Application
    Filed: March 24, 2022
    Publication date: August 25, 2022
    Inventors: Walter Low, Clifford Steer, Michael D. Finch, Cyrus B. Munshi
  • Publication number: 20210122780
    Abstract: Methods of preventing or retarding or reversing or abolishing the onset of Parkinson's and other neurodegenerative diseases are discussed.
    Type: Application
    Filed: March 29, 2019
    Publication date: April 29, 2021
    Inventors: Walter Low, Clifford Steer, Michael D. Finch, Cyrus B. Munshi
  • Publication number: 20210024973
    Abstract: A method of using microfluidic chips to significantly accelerate the time to identify and quantify microbes in a biological sample and test them for antibiotic resistance, particularly for urinary tract infections. A first microfluidic chip uses antibody or similar probes to identify and quantify any microbes present. The same or a similar chip uses antibody or similar probes to identify microbes with DNA or RNA known to indicate antibiotic resistance. Another microfluidic chip tests for antibiotic susceptibility of any microbes by growing them in very small wells in the presence of antibiotics, reducing the time required for such testing by as much as 95%. Another microfluidic chip runs traditional urinalysis or similar tests.
    Type: Application
    Filed: July 23, 2020
    Publication date: January 28, 2021
    Applicant: Urinary Technologies, Inc.
    Inventors: Michael D. FINCH, Kee Onn FONG, Saurabh KOTIAN, Cyrus B. MUNSHI, Advitiya MAHAJAN, Beth A. LINDBORG
  • Patent number: 10738342
    Abstract: Several microfluidic chips are used to significantly accelerate the time to identify and quantify microbes in a biological sample and test them for antibiotic resistance, particularly for urinary tract infections. A first microfluidic chip uses antibody or similar probes to identify and quantify any microbes present. The same or a similar chip uses antibody or similar probes to identify microbes with DNA or RNA known to indicate antibiotic resistance. Another microfluidic chip tests for antibiotic susceptibility of any microbes by growing them in very small wells in the presence of antibiotics, reducing the time required for such testing by as much as 95%. Another microfluidic chip runs traditional urinalysis or similar tests.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: August 11, 2020
    Assignee: Urinary Technologies, Inc.
    Inventors: Michael D. Finch, Kee Onn Fong, Saurabh Kotian, Cyrus B. Munshi, Advitiya Mahajan, Beth A. Lindborg
  • Publication number: 20200071740
    Abstract: Several microfluidic chips are used to significantly accelerate the time to identify and quantify microbes in a biological sample and test them for antibiotic resistance, particularly for urinary tract infections. A first microfluidic chip uses antibody or similar probes to identify and quantify any microbes present. The same or a similar chip uses antibody or similar probes to identify microbes with DNA or RNA known to indicate antibiotic resistance. Another microfluidic chip tests for antibiotic susceptibility of any microbes by growing them in very small wells in the presence of antibiotics, reducing the time required for such testing by as much as 95%. Another microfluidic chip runs traditional urinalysis or similar tests.
    Type: Application
    Filed: August 26, 2019
    Publication date: March 5, 2020
    Applicant: Urinary Technologies, Inc.
    Inventors: Michael D. FINCH, Kee Onn FONG, Saurabh KOTIAN, Cyrus B. MUNSHI, Advitiya MAHAJAN, Beth A. LINDBORG
  • Patent number: 10144758
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the bile acids such as ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium. Also disclosed are pharmaceutical compositions and methods of using the deuterated bile acids.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: December 4, 2018
    Assignee: Metselex, Inc.
    Inventors: Michael D Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia M. P. Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20180154050
    Abstract: Compositions, implantation devices and methods for stimulating an immune response to infection are discussed. In some examples, the compositions, implantation devices or methods of regulating the amplification of an adaptive immune response to infection involves use of one or more particles locally at a surgical or implant site to control bacterial infections without detrimental systemic side-effects. In some examples, the particles can be coated or layered onto the surface of an implantable device or material. In other examples, the particles can be injected into the site of implantation.
    Type: Application
    Filed: September 22, 2017
    Publication date: June 7, 2018
    Inventors: William Wustenberg, Michael D. Finch, Cyrus B. Munshi
  • Patent number: 9987396
    Abstract: Compositions, implantation devices and methods for stimulating an immune response to infection are discussed. In some examples, the compositions, implantation devices or methods of regulating the amplification of an adaptive immune response to infection involves use of one or more particles locally at a surgical or implant site to control bacterial infections without detrimental systemic side-effects. In some examples, the particles can be coated or layered onto the surface of an implantable device or material. In other examples, the particles can be injected into the site of implantation.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: June 5, 2018
    Assignee: BIOSPHERES, INC.
    Inventors: William Wustenberg, Michael D Finch, Cyrus B. Munshi
  • Publication number: 20180030084
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: July 17, 2017
    Publication date: February 1, 2018
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia M.P. Rodrigues, Susana Dias Lucas de Oliveira
  • Patent number: 9708362
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: July 18, 2017
    Assignee: Metselex, Inc.
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia Rodrigues, Susana Dias Lucas de Oliveria
  • Publication number: 20160168189
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 16, 2016
    Applicant: Metselex, Inc.
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia Rodrigues, Susana Dias Lucas de Oliveria
  • Publication number: 20150112089
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: October 22, 2014
    Publication date: April 23, 2015
    Applicant: Metselex, Inc.
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia Rodrigues, Susana Dias Lucas de Oliveira
  • Patent number: 7322659
    Abstract: A braking distribution system is provided for system with a front regenerative braking system and a rear regenerative braking system. The system comprises a brake controller coupled to the front regenerative braking system and the rear regenerative braking system, and the brake controller is configured to receive a braking request, a first amount of braking that is available from the front regenerative braking system, and a second amount of braking that is available from the rear regenerative braking system. The controller is also configured to calculate a front base braking based at least in part on the braking request and a front base braking distribution, calculate a rear base braking based at least in part on the braking request and a rear base braking distribution, and determine a front regenerative braking request and a rear regenerative braking request based on the first amount and the second amount.
    Type: Grant
    Filed: August 4, 2005
    Date of Patent: January 29, 2008
    Assignee: GM Global Technology Operations, Inc.
    Inventors: Michael D. Finch, Timothy M. Karnjate, Kevin S. Kidston, William K. Manosh, Kurtis C. Minney